Helmy Eltoukhy, Chief Executive Officer at Guardant Health, Inc. (GH), sold 400,253 shares at $160.35 ($63.9M) on 2021-04-07, disclosed to the SEC on 2021-04-09.
Open-market sale of $63.9M GH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.75 | 3,012 | $472K | 0.7% |
| 2 | $157.72 | 16,474 | $2.6M | 4.1% |
| 3 | $157.72 | 16,474 | $2.6M | 4.1% |
| 4 | $158.52 | 5,055 | $801K | 1.3% |
| 5 | $158.52 | 5,055 | $801K | 1.3% |
| 6 | $160.01 | 8,331 |
| $1.3M |
| 2.1% |
| 7 | $160.01 | 8,331 | $1.3M | 2.1% |
| 8 | $160.35 | 2,771 | $444K | 0.7% |
| 9 | $160.35 | 2,771 | $444K | 0.7% |
| 10 | $162.16 | 1,200 | $195K | 0.3% |
| 11 | $159.48 | 13,127 | $2.1M | 3.3% |
| 12 | $159.48 | 13,127 | $2.1M | 3.3% |
| 13 | $160.13 | 35,805 | $5.7M | 9.0% |
| 14 | $160.13 | 35,805 | $5.7M | 9.0% |
| 15 | $161.14 | 57,584 | $9.3M | 14.5% |
| 16 | $161.14 | 57,584 | $9.3M | 14.5% |
| 17 | $161.97 | 16,330 | $2.6M | 4.1% |
| 18 | $161.97 | 16,330 | $2.6M | 4.1% |
| 19 | $155.89 | 13,866 | $2.2M | 3.4% |
| 20 | $155.89 | 13,866 | $2.2M | 3.4% |
| 21 | $157.03 | 36,600 | $5.7M | 9.0% |
| 22 | $157.49 | 10,225 | $1.6M | 2.5% |
| 23 | $157.49 | 10,225 | $1.6M | 2.5% |
| 24 | $158.79 | 305 | $48K | 0.1% |
| Total | $159.55 avg | 400,253 | $63.9M | 100% |
| Filing → |
| GH | SELL | 2025-09-11 | $35.7M | — | Filing → |
| GH | BUY | 2023-03-16 | $4.7M | — | Filing → |
| GH | BUY | 2021-11-23 | $17.7M | — | Filing → |